McKinsey examines consumer goods and retail in the wake of COVID-19
Consulting firm McKinsey has some very useful economic and industry reports, research studies, and regular briefings.
Are business valuations less reliable during COVID-19? (No.)
Independent business valuers may face this question from clients or, if they’re testifying, from the opposing side.
Mercer using a 1% COVID-19 risk premium—for now
Veteran business valuer Chris Mercer (Mercer Capital) was a keynote speaker at the New York State Society of CPAs Business Valuation/Litigation Services Conference, which was held online on May 18.
How COVID-19 Is Impacting the IRS and Valuation Audits
Still reeling from the effects of the government shutdown and budget cutbacks, the pandemic has dealt another blow to the IRS that has affected how the agency selects and reviews tax returns that include valuations. A former IRS manager who dealt with valuations at the agency gives some interesting insights.
Valuing Full-Service Restaurants: Six Key Considerations in Today’s Market
The final chapter on the impact of the pandemic on the full-service restaurant sector has yet to be written. In the meantime, thinking continues to evolve on conducting valuations in the current environment. In a new special report, What It’s Worth: Valuing Full-Service Restaurants, BVR covers the fundamentals and unique considerations for restaurant valuation—as well as how to assess the long-term outlook for consumer preferences and financial performance. Based on conversations, webinars, and conference sessions with many valuation experts, here are six pandemic-related issues you should consider.
Physician Compensation and Valuation: Administering Top Tier Treatment
Assessing physician compensation is a critical component in valuing a physician practice. Many external factors, including the COVID-19 pandemic and proposed changes to the Medicare Physician Fee Schedule, have had and will continue to have significant impacts on physician compensation and associated practice valuations. In this discussion, Derek Long and Katie Culver will explain how physician compensation is analyzed in the context of valuation along with various factors that can influence it, both internally and ...
Valuation of Senior Living and Post-Acute Providers
Join Jed Cheney to learn the considerations when valuing senior living and post-acute healthcare providers ranging from assisted living and memory care to skilled nursing and home health/hospice providers. With insights on the industry at large and government reimbursement considerations along with environmental considerations in the senior living and post-acute provider operating environment, this webinar will focus on various value drivers impacting these providers that should be considered. The impacts of COVID-19 have been significant ...
Some further thoughts on ‘most likely outcome’ forecasts for business valuation
Every financial analyst is struggling with forecasting methodologies now.
Extreme Uncertainty: How Valuation Experts Should Respond to Today’s Volatility and Risk
In this town hall-style event, Michelle Gallagher, Gary Trugman, Stacy Collins, and Harold Martin talk through key impacts of COVID-19 on valuation issues. From cost of capital to family law to guideline companies, the impact on the inputs, approaches, and the business we value is profoundly felt. Experts who have weathered financial crises before are doing a yeoman’s job of keeping current with the ever-changing information. Send early questions and comments to questions@bvresources.com. Invite your ...
SEC comment letters uncover COVID-19 disclosures per PwC analysis
Valuable information can be gleaned about fair value measurement issues from comment letters the Securities and Exchange Commission (SEC) sends after it reviews public companies’ financial statements and disclosures.
BVFLS conference in Virginia September 19-20
Last year, BVWire attended the Business Valuation, Fraud & Litigation Services Conference sponsored by the Virginia Society of CPAs (see some prior coverage here).
SEC Comment Letters Reveal COVID-19 Impacts—and Much More
How to benefit from the great deal of useful information about fair value measurement issues in comment letters the Securities and Exchange Commission (SEC) sends after it reviews public companies’ financial statements and disclosures.
AICPA issues FAQs on valuation considerations related to the CARES Act
The latest in a series of very useful material from the AICPA is a document that includes FAQs that address questions about the impact of the CARES Act on business valuation.
M&A impacts discussed during recent BVR town hall
There were several questions about M&A activity amid the coronavirus crisis during BVR’s recent town hall webinar.
BVWire to cover AICPA FVS conference November 9-11
BVWire is looking forward to the AICPA’s Forensic and Valuation Services Conference live online November 9-11.
Goodwill impairments fell 10% in 2019: D&P study
Total goodwill impairment declined to $71 billion in 2019, down 10% from $78.9 billion in 2018, according to the “2020 U.S. Goodwill Impairment Study” by Duff & Phelps.
Goodwill impairments in U.S. doubled in 2020: Kroll study
Total goodwill impairment in U.S. public companies was $142.5 billion in 2020, more than double the $71 billion recorded in 2019, according to the “2021 U.S. Goodwill Impairment Study” by Kroll.
‘Absurd’ CAPM, Size Impact, ‘Sense Checks,’ and Family Firms Highlight the ICAEW Conference
Excellent speakers and interesting topics were on hand at the valuation conference of the Institute of Chartered Accountants in England and Wales (ICAEW) in the United Kingdom.
Plaintiff’s COVID-Related Contract Claim Falters Despite Force Majeure Provision
Court says plaintiff fails to show defendant breached contract in COVID-19-related damages case; plaintiff’s invocation of force majeure clause is futile where clause is silent as to whether plaintiff has a right to full deposit after termination of contract due to imposed travel restrictions.
Caesars Entertainment sues over COVID-19-related economic damages
On March 19, Caesars Entertainment joined the long list of businesses that have filed lawsuits against their insurance companies for refusing to pay business interruption losses stemming from COVID-19-related government shutdowns of economies across the nation and world.
When market data are volatile, the best alternative is a more rigorous DCF
Quarterly economic indicators are barely sufficient for business valuers now.
New World of Energy Valuations, Per Speakers at the ASA Houston Conference
How have valuations been upended in this sector? What’s the outlook for all of the regulatory and tax proposals? When will this sector rebound? The answers may surprise you.
Valuation of Specialty Pharmacies – Practical Considerations
Do you know the elements to consider when performing a valuation assignment for a specialty pharmacy? Join Jarrod Barraza for a dive into the industry and regulatory backdrop and recent history. Learn about the outlook and market trends with a focus on operational considerations. Discuss the valuation considerations, and hear from Mike Gerling, an expert in the specialty pharmacy industry, who will provide insight as an operator. With a focus on practical considerations when conducting ...
NetOne, Inc. v. Panache Destination Management
Court says plaintiff fails to show defendant breached contract in COVID-19-related damages case; plaintiff’s invocation of force majeure clause is futile where clause is silent as to whether plaintiff has a right to full deposit after termination of contract due to imposed travel restrictions.
2023 Overview of the Marijuana Industry: The Coming Wave of Consolidation and Beyond. Opportunities Abound!
The session will explore current trends and engagement opportunities in the cannabis industry. The continuing conflict between federal and state laws and regulations, coupled with the economic impact of inflation, the illicit cannabis market, and the aftermath of the COVID pandemic pause have resulted in a perfect storm for an incredibly unique industry. Recreational use of marijuana is currently legal for adults in 21 states and Washington, D.C., while medical marijuana is legal and available ...